Upgrade to SI Premium - Free Trial

Eagle Pharmaceuticals (EGRX) PT Lowered to $64 at RBC Capital

November 2, 2018 7:01 AM
RBC Capital analyst Randall Stanicky lowered the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles